Busche MN, Pavlov V, Takahashi K, Stahl GL. Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin. Am J Physiol Heart Circ Physiol 297: H1853-H1859, 2009. First published September 11, 2009 doi:10.1152/ajpheart.00049.2009.-Complement activation has been shown to play an important role in the inflammation and tissue injury following myocardial ischemia and reperfusion (MI/R). Several recent studies from our laboratory demonstrated the importance of mannose-binding lectin (MBL) as the initiation pathway for complement activation and the resulting pathological effects following MI/R. However, other studies from the past suggest an important role of the classical pathway and perhaps natural antibodies. In the present study, we used newly generated genetically modified mice that lack secreted IgM (sIgM), MBL-A, and MBL-C (sIgM/MBL null) in a plasma reconstitution mouse model of MI/R. Following 30 min of ischemia and 4 h of reperfusion, left ventricular ejection fractions were significantly higher in sIgM/MBL null mice reconstituted with MBL null or sIgM/MBL null plasma compared with reconstitution with wild-type (WT) plasma or WT mice reconstituted with WT plasma following MI/R. Serum troponin I concentration, myocardial polymorphonuclear leukocyte infiltration, and C3 deposition were dependent on the combined presence of sIgM and MBL. These results demonstrate that MI/R-induced complement activation, inflammation, and subsequent tissue injury require both IgM and MBL. Thus MBL-dependent activation of the lectin pathway may not be completely antibody independent in I/R models.
MYOCARDIAL ISCHEMIA AND REPERFUSION (MI/R) injury occurs following the restoration of blood flow after transient ischemia in the heart (27, 28) . During ischemia, myocardial cells undergo intrinsic changes leading to perturbations in surface molecule expression and the formation of neoantigens, making the affected cells targets for the innate immune system (16) . Though the reestablishment of oxygenated blood flow is critical for myocardial salvage, it also results in significant damage of the reperfused tissue. It is thought that the immune response directed toward the neoantigens exposed as a result of the relative hypoxia causes the injury (7) . This phenomenon remains a significant barrier to the otherwise restorative potential of reperfusion therapy in ischemic heart disease. Complement has been shown to be an important contributor to myocardial inflammation and tissue injury following MI/R for over 30 years (16) . The inhibition of complement with protease inhibitors, specific anticomplement biologics, and the use of genetically modified animals demonstrate that the inhibition of complement decreases inflammation and tissue injury following MI/R (3, 16, 22, 29, 31) . A recent clinical trial also suggested an important role in humans (1, 14) . Thus complement activation appears to play an important role in MI/R in multiple species.
Complement is part of the innate immune system. Complement can be activated by at least three separate pathways: classical, alternative, and lectin. All three pathways merge at the complement subcomponent C3 and cleave C3 into C3b and C3a, followed by the formation of a C5 convertase and cleavage of C5 into C5a and C5b. The anaphylatoxin C5a is a potent activator of inflammation and a chemoattractant for inflammatory cell populations, including polymorphonuclear leukocytes (PMNs), whereas C5b can interact with C6, C7, C8, and multiple C9 units to form the terminal complement complex C5b-9. C5b-9 formation can lead to cellular activation or lysis of anuclear cells (27, 28) . Natural antibodies interacting with neoantigens form antigen-antibody complexes that are capable of activating the classical pathway are thought to mediate tissue injury following oxidative stress (2, 9, 33, 34) . In contrast, the lectin and alternative complement pathways are historically known to activate complement in an antibodyindependent manner. The lectin complement pathway can be activated by carbohydrate recognition domains on the initiation molecules of the lectin pathway [e.g., ficolins and mannosebinding lectin (MBL)]. MBL binds to human endothelial cells following oxidative stress and activates complement (11, 12) . C3b deposition from either the classical or lectin pathway can be used to initiate the alternative Pathway and serves to amplify complement activation (i.e., tick-over amplification).
Natural antibodies and the classical pathway were demonstrated to play an important role in ischemia-reperfusion (I/R) models, as well as MI/R (3, 5, 17, 23, 34) . In contrast, our laboratory demonstrated in genetically modified mice lacking C1q (e.g., classical pathway inhibited) or MBL (e.g., lectin pathway inhibited) or specific inhibition of MBL with antibodies that the MBL-dependent portion of the lectin complement pathway plays an important role in tissue injury and inflammation following MI/R (19, 29) . Thus it appears that the lectin pathway plays an important role in the initiation of complement activation following MI/R, but the role of natural antibodies in this process is not known. In the present study, we used a novel triple genetically modified mouse that lacks secreted IgM (sIgM), MBL-A, and MBL-C (sIgM/MBL null) to determine whether MBL, IgM, or both are needed to initiate complement activation following MI/R. IgM and MBL were reconstituted by the addition of specific plasma from additional mice [e.g., wild-type (WT), sIgM, MBL null, and sIgM/MBL null].
MATERIALS AND METHODS
Mice. All animals used in the MI/R experiments were male mice 8 -12 wk old. We obtained C57BL/6 mice from Charles River Laboratories (Wilmington, MA). MBL null mice, sIgM null mice, and mice deficient in sIgM and MBL-A/-C (sIgM/MBL null) were backcrossed seven generations onto the C57BL/6 background as previously described (21) . The MBL null, sIgM null, and sIgM/MBL null mice were backcrossed while monitoring the genetic background using microsatellite analysis so that the mice were 96% C57BL/6. All procedures were reviewed and conducted in accordance with the Institute's Animal Care and Use Committee. We performed the experiments according to the standards and principles set forth in the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health (NIH Publication No. 85-23, Revised 1996).
Reconstitution and MI/R experiments. To collect plasma for the reconstitution experiments, WT, MBL null, sIgM null, and sIgM/ MBL null mice were anesthetized with isoflurane and heparinized (20 units; American Pharmaceutical Partners, Los Angeles, CA), and blood was collected by cardiac puncture. Blood was centrifuged at 1,000 g for 10 min, and plasma was collected as previously described (21) . Experimental MI/R was performed as previously published (6, 29) . Briefly, mice were intubated and ventilated, and anesthesia was maintained with isoflurane. Freshly harvested plasma (350 l) was administered via penile vein injection. The chest was opened, and a suture was placed around the left anterior descending coronary artery and tightened. After 30 min of ischemia, the ligation was loosened and the myocardium reperfused for 4 h. An electrocardiogram (modified lead III) was evaluated before, during, and after ischemia and used to verify ischemia and reperfusion. Left ventricular discoloration/dyskinesis and its reversal were also visualized for additional documentation of ischemia and reperfusion, respectively.
We used five experimental groups in this study as follows: shamoperated WT mice reconstituted with WT plasma (sham surgery in the presence of IgM and MBL) and the following four groups of mice undergoing MI/R: WT mice reconstituted with WT plasma (control for plasma addition and extra complement components), sIgM/MBL null mice reconstituted with WT plasma (IgM and MBL present), or MBL null plasma (IgM present; MBL absent), or reconstituted with sIgM/MBL null plasma (control for complement components and plasma volume, but IgM and MBL absent). In an additional study, we reconstituted sIgM/MBL null mice with sIgM null plasma (MBL present; IgM absent) and looked at C3 deposition as an additional control for complement activation following MI/R.
Echocardiography. Echocardiography was performed after mice had undergone experimental MI/R to assess cardiac function. We previously demonstrated myocardial injury via histological infarct analysis and that it is directly correlated to the loss of cardiac function as measured by echocardiography (6, 29) . Echocardiography was performed by a researcher blinded to the treatment group 4 h after reperfusion using a Philips Sonos 5500 (Philips Medical Systems, Bothell, WA) with a 7-12-MHz animal transducer (Agilent Technologies, Santa Clara, CA), as we described (6, 29) . Ejection fraction (EF) was calculated as the mean of three separate measurements via left ventricular M-mode measurements as well as two-dimensional imaging via long-axis length and short-axis area measurements of the left ventricle (20, 24) . For EF, only M-mode data are presented, as both methods of EF measurement produced identical results, as we previously demonstrated (6) .
Collection of blood and tissue. Following reperfusion and the echocardiographic studies, the chest cavity was opened, the inferior caval vein was cut, and blood was collected from the thoracic cavity. Hearts were excised and fixed in 10% formalin PBS at 4°C overnight.
Serum troponin I concentrations. Serum troponin I concentrations were measured as an index of myocardial cell death using a commercially available ELISA kit as we described (Life Diagnostics, West Chester, PA) (6, 26) .
Histological sections and staining for PMNs and myocardial deposition of C3. Formalin-fixed hearts were dehydrated, embedded in paraffin, and cut from cranial to caudal into 7-m sections. We used comparable sections for each heart, so the staining was performed on similar levels of the heart. Thus there was no need to compare different areas of each section, as each section represents a cut through the entire heart and each section was evaluated in total by quantitative pixel analysis. To evaluate myocardial PMN infiltration and C3 deposition, the sections were dewaxed with EZ-DeWax solution (BioGenex, San Ramon, CA) and incubated with blocking buffer containing 5% normal sheep serum (for PMN) or donkey serum (for C3 deposition) for 1 to 2 h at room temperature. Primary antibody incubation for PMN identification used a rat anti-mouse Ly-6G monoclonal antibody (BD Pharmingen, Franklin Lakes, NJ) for 1 to 2 h at room temperature as previously described (6, 13) . Staining for myocardial C3 deposition used a goat anti-mouse C3 antibody (MP Biomedicals) for 1 to 2 h at room temperature as described (6) . Following primary antibody incubation, the slides were washed four times for 15 min each with TBS-Tween and then incubated with a secondary sheep anti-rat IRDye800 antibody or donkey anti-goat IRDye800 antibody (Rockland Immunochemicals, Gilbertsville, PA) for 1 to 2 h at room temperature. After the slides were washed four times for 15 min each, the excess fluid was removed and the slides were covered with Gel Mount (Biomeda, Foster City, CA) and coverslips (Fisher Scientific, Pittsburgh, PA) and then sealed after 1 h with clear nail polish.
The sections were scanned and quantitatively analyzed for PMN infiltration or C3 deposition with an Odyssey infrared imaging system (LI-COR, Lincoln, NE) at 800 nm as we validated and documented previously (6) . Briefly, myocardial sections stained for PMN or C3 deposition were quantitatively analyzed by pixel counting using ImageJ software (NIH). To count cardiac PMN per high-powered field or quantitatively analyze C3 deposition by pixel counting in fluorescence imaging, we used the staining protocol described for the Odyssey infrared imaging system, except that a FITC-conjugated secondary antibody was used. PMNs per field were counted and C3 deposition was quantitatively analyzed by pixel counting using ImageJ software (NIH) via fluorescence imaging at ϫ100 magnification using a Nikon Eclipse microscope (Nikon Instruments) in three different areas of each myocardial section for three mice per group.
Statistical analyses. We performed all statistical analysis of the data using SigmaStat software (SPSS, Chicago, IL). We evaluated all the data using one-way ANOVA and post hoc analysis using the Student-Newman-Keuls method. All data are expressed as means Ϯ SE.
RESULTS

Echocardiography.
Following 30 min of ischemia and 4 h of reperfusion, we observed a significant decrease in left ventricular EF in WT mice or sIgM/MBL null mice reconstituted with WT plasma compared with the sham-operated control group (WT mice reconstituted with WT plasma) (Fig. 1, A and B) . Serum troponin I concentrations. Serum troponin I concentrations provided biochemical findings that confirmed and supported the echocardiographic observations. Sham-operated WT mice reconstituted with WT plasma did not present detectable serum troponin I concentrations (data not shown). Thirty minutes of ischemia and 4 h of reperfusion in WT mice or sIgM/MBL null mice reconstituted with WT plasma significantly increased serum troponin I concentrations (Fig. 2) . In confirmation of our echocardiographic findings, sIgM/MBL null mice reconstituted with MBL or sIgM/MBL null plasma had significantly reduced serum troponin I concentrations compared with WT mice or sIgM/MBL null mice reconstituted with WT plasma (Fig. 2) . These data support the hypothesis that MI/R-related leakage of troponin I requires both MBL and IgM.
Myocardial PMN infiltration. PMN infiltration into the cardiac tissue as a measure of MI/R-related inflammation mirrored our echocardiography and serum troponin I observations (Fig. 3,  A and B) . Sham-operated WT mice reconstituted with WT plasma displayed no significant PMN infiltration. In contrast, 30 min of ischemia and 4 h of reperfusion induced a significant inflammatory response in WT mice or sIgM/MBL null mice reconstituted with WT plasma (Fig. 3, A and B) . sIgM/MBL null mice reconstituted with MBL null or sIgM/MBL null plasma displayed significantly reduced inflammatory infiltrates compared with WT mice or sIgM/MBL null mice reconstituted with WT plasma (Fig. 3, A and B) . Hand-counting PMNs in cardiac tissue validated our results using the Odyssey infrared imaging system as we previously published (6) . WT mice or sIgM/MBL null mice reconstituted with WT plasma undergoing 30 min of ischemia and 4 h of reperfusion revealed a significant increase in the inflammatory response compared with sham-operated WT mice reconstituted with WT plasma [21 Ϯ 2 and 18 Ϯ 2 vs. 3 Ϯ 1 (P Ͻ 0.001) PMN per high-powered field, respectively]. sIgM/MBL null mice reconstituted with MBL null or sIgM/MBL null plasma undergoing 30 min of ischemia and 4 h of reperfusion displayed significantly reduced inflammatory infiltrates compared with WT mice or sIgM/MBL null mice reconstituted with WT plasma [5 Ϯ 1 and 6 Ϯ 1 vs. 21 Ϯ 2 and 18 Ϯ 2 PMNs per high-powered field (P Ͻ 0.001), respectively]. These data suggest that the MI/R-induced inflammatory response is dependent on both IgM and MBL.
Myocardial C3 deposition. Myocardial C3 deposition was used as a marker of complement activation in the reperfused ischemic myocardium that is dependent on MBL-dependent lectin complement pathway activation as we previously demonstrated (19, 29) . Sham-operated WT mice reconstituted with WT plasma displayed no significant deposition of C3 (Fig. 4,  A and B) . In contrast, 30 min of ischemia and 4 h of reperfusion induced a significant C3 deposition in WT or sIgM/MBL null mice reconstituted with WT plasma (Fig. 4, A and B) . In contrast, sIgM/MBL null mice reconstituted with MBL null, sIgM null, or sIgM/MBL null plasma demonstrated significantly reduced C3 deposition compared with WT mice or sIgM/MBL null mice reconstituted with WT plasma (Fig. 4, A  and B) . These data confirm the need of IgM and MBL for complement activation in this model. C3 was also quantitatively analyzed by pixel counting in fluorescence imaging, as we previously used to validate the infrared methods used in the Odyssey system (6). WT mice or sIgM/MBL null mice reconstituted with WT plasma undergoing 30 min of ischemia and 4 h of reperfusion demonstrated a significant increase in C3 deposition compared with shamoperated WT mice reconstituted with WT plasma [42 Ϯ 7 and 31 Ϯ 6 vs. 2 Ϯ 1 (P Ͻ 0.001) ϫ 10 3 pixels per high-powered field, respectively]. sIgM/MBL null mice reconstituted with MBL null or sIgM/MBL null plasma undergoing 30 min of ischemia and 4 h of reperfusion revealed significantly reduced C3 deposition compared with WT mice or sIgM/MBL null mice reconstituted with WT plasma [6 Ϯ 1 and 7 Ϯ 2 vs. 42 Ϯ 7 and 31 Ϯ 6 ϫ 10 3 pixels per high-powered field (P Ͻ 0.001), respectively].
DISCUSSION
Role of complement in MI/R injury. The role of complement in tissue injury and inflammation following MI/R has been studied for the past 30 plus years (16) . Many studies demonstrated that complement inhibition provides cardioprotective and anti-inflammatory results following MI/R (3, 16, 19, 22, 29, 31) . However, the role of the three complement pathways in MI/R has been a subject with diverse results. Studies have demonstrated the importance of natural antibodies, deposition of C1q in the infarcted tissue, as well as specific serine protease inhibitor against C1s providing tissue protection, suggesting an important role of the classical pathway (3, 5, 17, 23, 34) . In contrast, we demonstrated that specific antibodies directed against MBL or genetically modified mice lacking MBL do not activate/deposit complement and provide cardioprotection in models of MI/R, whereas the deletion of C1q was ineffective (19, 29) . Thus these seemingly discordant results from differing laboratories left many researchers questioning the specific role of natural antibodies, MBL, C1q, and the classical/lectin pathways in MI/R.
Plasma reconstitution mouse model of MI/R. In this study, we used a novel triple genetically modified mouse that lacks sIgM, MBL-A, and MBL-C (sIgM/MBL null) in a mouse model of MI/R to investigate the role of natural antibodies in an MBL-dependent activation of the lectin complement pathway. Mice were reconstituted by the addition of specific plasma from additional mice (WT plasma ϭ IgM ϩ MBL, MBL null plasma ϭ IgM only, sIgM/MBL null plasma ϭ no IgM or MBL, and sIgM null plasma ϭ MBL only). A verification of complement activation following MI/R is easily obtained by looking at myocardial C3 deposition, which can be deposited by any of the three complement pathways. While the concentration of IgM and MBL would be lower in the sIgM/ MBL null group reconstituted with WT plasma compared with the WT group reconstituted with WT plasma, we did observe an increased C3 deposition compared with the reconstitution of the sIgM/MBL null mice with either MBL null, sIgM/MBL null, or sIgM null plasma. These data demonstrate that for complement activation to occur in this MI/R model, both IgM and MBL must be present. These data also suggest that IgM and MBL must be interacting together to activate complement following MI/R, which we previously demonstrated in vitro and in vivo in different models (21) .
Role of natural antibodies in MBL-dependent activation of the lectin complement pathway. While the MBL-dependent portion of the lectin complement pathway is historically known as the "other antibody-independent pathway" (in addition to the alternative pathway), we recently demonstrated that MBL does interact with IgM to activate complement in cellular and animal models (21) . The results in the present study also confirm our previous findings observed in a gastrointestinal I/R model (21) . While we previously demonstrated that MBL is the initiation molecule for complement activation in the ischemic myocardium (19, 29) , we now extend these findings to include an important role for natural antibodies, particularly IgM. In the present study, we observe that in the absence of IgM, there is significantly less organ dysfunction (Fig. 1, A and B) , irreversible tissue injury (Fig. 2) , and inflammation (Fig. 3, A  and B) following MI/R compared with those in animals having both IgM and MBL. More importantly, we demonstrate that complement activation and the resulting myocardial C3 deposition, which is known to be MBL dependent following MI/R (19, 29) but C1q and classical pathway independent (29) , are dependent on the presence of IgM (Fig. 4, A and B) . Similar observations by others also support an antibody-dependent activation of the MBL-dependent lectin pathway following I/R (8, 34) . Our data indicate for the first time that MI/R-induced complement activation and subsequent injury requires both IgM and MBL. Furthermore, these findings extend the hypothesis that the activation of the MBL-dependent lectin complement pathway may not be completely antibody independent.
Controversial contribution of individual complement pathways in MI/R injury. The discrepancy in the literature between the roles of the classical versus lectin complement pathways in I/R might be explained by study design. Previous studies implicating the classical pathway as the major initiating and the only antibody-dependent pathway of complement activation following I/R have used nonspecific means of inhibition (3, 4, 17, 30, 32) . For example, the protection from tissue injury observed in C4 KO mice following I/R could be due to the lack of the classical or lectin pathways in these mice (30, 32) . Additionally, it is known that MBL can activate the alternative complement pathway in C2 and C4 deficiency states (18, 25) . The use of a C1 inhibitor has been shown to inhibit both the classical and lectin pathways (10) , and the C1s inhibitor (a serine protease inhibitor) was never tested against MBL-associated serine protease-2 (3); therefore, the protective effects of these inhibitors could be due to an inhibition of either the classical and/or lectin pathways (3, 5, 17) . In contrast, studies using MBL null and C1qa null mice have shown in a more specific way that the MBL-dependent lectin pathway, and not the classical pathway, activates complement following gastrointestinal I/R and MI/R (15, 29) . Also, the results from the present study suggest that lectin complement pathway activation could be antibody dependent, similar to that observed in the gastrointestinal I/R model (21) . Thus the observed antibody-dependent activation of the complement system in earlier studies with nonspecific means of complement inhibition (which was attributed to the classical pathway) may have missed the importance of antibody-dependent activation of the lectin pathway in I/R injury.
Conclusion. In summary, we demonstrate and extend our previous studies that the MBL-dependent portion of the lectin complement pathway is responsible for complement activation following MI/R. Furthermore, we demonstrate the importance and need for IgM for complement activation, tissue inflammation, and injury following MI/R. Therefore, we propose a model in which IgM binds to myocardial and/or endothelial neoepitopes during ischemia and reperfusion. The binding of MBL to IgM during reperfusion initiates lectin-dependent complement pathway activation, which then contributes to MI/R-induced tissue inflammation and injury.
